A randomized double-blind cross-over trial to study the effects of resistant starch prebiotic in chronic kidney disease (ReSPECKD).
Maryam ShamlooRebecca MollardHaizhou WangKulwant KingraNavdeep TangriDylan S MacKayPublished in: Trials (2022)
ClinicalTrials.gov NCT04961164 . Registered on 14 July 2021.